Literature DB >> 7678779

The zinc finger transcription factor Egr-1 is essential for and restricts differentiation along the macrophage lineage.

H Q Nguyen1, B Hoffman-Liebermann, D A Liebermann.   

Abstract

We have isolated cDNA clones of myeloid differentiation primary response (MyD) genes, activated in the absence of de novo protein synthesis following induction for differentiation along either the macrophage or granulocyte lineage in human myeloblastic leukemia HL-60 cells. One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor. The Egr-1 gene was observed to be transcriptionally silent in HL-60 cells, but active in U-937 and M1 cells, the latter two being predetermined for macrophage differentiation. Egr-1 antisense oligomers in the culture media blocked macrophage differentiation in both myeloid leukemia cell lines and normal myeloblasts. HL-60 cells constitutively expressing an Egr-1 transgene (HL-60Egr-1) could be induced for macrophage, but not granulocyte, differentiation. These observations indicate that expression of Egr-1 is essential for and restricts differentiation of myeloblasts along the macrophage lineage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7678779     DOI: 10.1016/0092-8674(93)90660-i

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  103 in total

1.  MafB is an inducer of monocytic differentiation.

Authors:  L M Kelly; U Englmeier; I Lafon; M H Sieweke; T Graf
Journal:  EMBO J       Date:  2000-05-02       Impact factor: 11.598

2.  Genetic background-dependent role of Egr1 for eyelid development.

Authors:  Jangsuk Oh; Yujuan Wang; Shida Chen; Peng Li; Ning Du; Zu-Xi Yu; Donna Butcher; Tesfay Gebregiorgis; Erin Strachan; Ordan J Lehmann; Brian P Brooks; Chi-Chao Chan; Warren J Leonard
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-04       Impact factor: 11.205

3.  Expression of Egr-1 in late stage emphysema.

Authors:  W Zhang; S D Yan; A Zhu; Y S Zou; M Williams; G C Godman; B M Thomashow; M E Ginsburg; D M Stern; S F Yan
Journal:  Am J Pathol       Date:  2000-10       Impact factor: 4.307

4.  [Egr-1 transcription factor regulates the growth of glomerular mesangium cells].

Authors:  H D Rupprecht; G Hofer; R B Sterzel; H O Schöcklmann
Journal:  Med Klin (Munich)       Date:  1997-02-15

Review 5.  Transcriptional regulation of myelopoiesis.

Authors:  Alan D Friedman
Journal:  Int J Hematol       Date:  2002-06       Impact factor: 2.490

6.  Egr-1: is it always immediate and early?

Authors:  S F Yan; D J Pinsky; N Mackman; D M Stern
Journal:  J Clin Invest       Date:  2000-03       Impact factor: 14.808

7.  High salt culture conditions suppress proliferation of rat C6 glioma cell by arresting cell-cycle progression at S-phase.

Authors:  Hideki Arimochi; Kyoji Morita
Journal:  J Mol Neurosci       Date:  2005       Impact factor: 3.444

8.  Paradoxical exacerbation of neuronal injury in reperfused stroke despite improved blood flow and reduced inflammation in early growth response-1 gene-deleted mice.

Authors:  Andrew F Ducruet; Sergey A Sosunov; Scott H Visovatti; Danica Petrovic-Djergovic; William J Mack; E Sander Connolly; David J Pinsky
Journal:  Neurol Res       Date:  2011-09       Impact factor: 2.448

9.  IFN regulatory factor 8 represses GM-CSF expression in T cells to affect myeloid cell lineage differentiation.

Authors:  Amy V Paschall; Ruihua Zhang; Chen-Feng Qi; Kankana Bardhan; Liang Peng; Geming Lu; Jianjun Yang; Miriam Merad; Tracy McGaha; Gang Zhou; Andrew Mellor; Scott I Abrams; Herbert C Morse; Keiko Ozato; Huabao Xiong; Kebin Liu
Journal:  J Immunol       Date:  2015-02-02       Impact factor: 5.422

10.  Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active.

Authors:  Takashi Shimada; Itaru Urakawa; Tamara Isakova; Yuji Yamazaki; Michael Epstein; Katherine Wesseling-Perry; Myles Wolf; Isidro B Salusky; Harald Jüppner
Journal:  J Clin Endocrinol Metab       Date:  2009-12-04       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.